Avadel Pharmaceuticals plc - American Depositary Shares each re — Quarterly Cash Flow (NASDAQ:AVDL) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 158.25 M164.24 M167.95 M187.16 M199.45 M Total liabilities 83.59 M90.39 M93.88 M96.45 M101.22 M Total equity 74.66 M73.85 M74.07 M90.71 M98.22 M Total liabilities & shareholders' equities 158.25 M164.24 M167.95 M187.16 M199.45 M Total debt ————— Net debt —————

ニュース

I risultati di Alkermes in arrivo mentre prende forma la strategia sul sonno

Alkermes earnings up next as sleep strategy takes shape

Harmony Biosciences Makes The Grade (NASDAQ:HRMY)

Obiettivo di prezzo di Alkermes alzato a $47 da $46 da UBS dopo l’accordo con Avadel

Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal

BlackRock rivela una partecipazione del 6,94% in Avadel Pharmaceuticals

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals

TIG Advisors rivela una partecipazione del 4,18% in Avadel Pharmaceuticals

TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals

Goldman Sachs rivela posizione di trading in Avadel Pharmaceuticals

Goldman Sachs discloses trading position in Avadel Pharmaceuticals

Janus Henderson rivela una partecipazione dell’1,87% in Avadel Pharmaceuticals